+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Global Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Forecast 2024-2030- Product Image
Global Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Forecast 2024-2030- Product Image
Sale

Global Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Forecast 2024-2030

  • PDF Icon

    Report

  • 192 Pages
  • May 2024
  • Region: Global
  • 360iResearch™
  • ID: 4807807
UP TO OFF until Dec 31st 2024
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Specialty Drug Distribution Market size was estimated at USD 4.76 billion in 2023, USD 5.47 billion in 2024, and is expected to grow at a CAGR of 14.44% to reach USD 12.25 billion by 2030.

Specialty drugs are normally complex to manufacture, high-cost medications requiring specialized handling, storage, and transport to maintain efficacy. The distribution channels are essential for specialty drugs, as they often require special handling and storage throughout the supply chain. Specialty drugs are expensive or hard to obtain; thus, a well-designed distribution strategy is necessary to ensure timely and proper access to the right patients. A distribution channel for specialty drugs allows for a smooth flow of specialty drugs from the manufacturer through the wholesaler to the pharmacy, ensuring that they arrive intact and promptly while adhering to safety standards.

By utilizing effective distribution methods, healthcare providers can ensure that specialty drugs are properly handled and safely transported while meeting necessary time-sensitive requirements. Robust distribution systems provide an extra layer of safety to guarantee that these temperature requirements are met throughout the supply chain. However, the complexity of managing different distribution channels and drug data and dynamic regulatory frameworks for specialty drug handling restricts the market growth. On the other hand, the rising expansion of specialty pharmacies and new advancements and technologies, including cold chain management and track & trace systems, among others, integrated for the seamless distribution of the specialty drug is aiming at enhancing the efficiency, safety, and overall patient experience in the distribution of specialty drugs.

Regional Insights

America's landscape for specialty drug distribution is complex and rapidly evolving, as the region has several prominent pharmaceutical manufacturing hubs, including the United States, Canada, and Brazil. These countries have well-established pharmaceutical industries and infrastructure to support the production and distribution of specialty drugs. Specialty drug distribution in the region is governed by the Food and Drug Administration (FDA), Health Canada, which regulates the approval, manufacturing standards, and distribution of pharmaceuticals, including specialty drugs, and ensures compliance with quality and safety standards.

Furthermore, countries such as China, India, Japan, South Korea, and Australia have robust pharmaceutical manufacturing capabilities and are increasingly investing in research and development of specialty drugs. This growth has led to expanding specialty drug distribution networks in the APAC region with their regulatory framework governing the distribution of specialty drugs. The EMEA region has a well-established regulatory framework for pharmaceuticals, including specialty drugs. The European Medicines Agency (EMA) in Europe, the Saudi Food and Drug Authority (SFDA) in Saudi Arabia, and the Medicines Control Council (MCC) in South Africa are some of the regulatory bodies that supervise the approval, quality standards, and distribution practices for pharmaceutical products. Moreover, the payers, such as health insurance companies and government programs, vary across countries, with different reimbursement models and access policies influencing the distribution and affordability of specialty drugs.

Market Trends by Segment

  • Disease Indication: Escalated need of specialty drugs to treat oncology conditions
  • Distributor Type: Rising presence of full line wholesalers of speciality drugs
  • Distribution Type: Significant penetration in specialty pharmacies
  • End-User: Emerging potential for specialty drug distribution in home settings

Industry Insights

  • Market Dynamics
  • Market Disruption Analysis
  • Porter’s Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis
  • FPNV Positioning Matrix
  • Market Share Analysis
  • Strategy Analysis and Recommendations

Recent Developments

FFF Enterprises Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Distributor of YCANTH, the First FDA Approved Treatment for Molluscum Contagiosum

FFF Enterprises Inc., a trusted specialty drug distributor and diversified healthcare company, has established a partnership with Verrica Pharmaceuticals Inc. to distribute YCANTH (cantharidin) Topical Solution 0.7%. YCANTH is the first FDA-approved treatment for molluscum contagiosum. This partnership aims to facilitate the availability of YCANTH, providing healthcare professionals with a reliable and efficient solution for treating molluscum contagiosum.

Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for VEOPOZ (pozelimab-bbfg), the First and Only Treatment for CHAPLE Disease

Orsini Specialty Pharmacy, an independent specialty pharmacy, has been named the exclusive specialty pharmacy partner for VEOPOZ (pozelimab-bbfg) by Regeneron Pharmaceuticals, Inc. VEOPOZ is the first and only treatment for those living with CHAPLE disease, a rare and life-threatening hereditary disorder caused by an overactivation of the complement system. Orsini Specialty Pharmacy is the exclusive specialty pharmacy for EVKEEZA (evinacumab-dgnb), another treatment for homozygous familial hypercholesterolemia (HoFH).

Medis and ESTEVE Signed a Distribution Agreement for 10 CEE Countries

Medis, a commercialization company for Central and Eastern Europe (CEE), has recently entered into a long-term agreement with ESTEVE, an international pharmaceutical innovator with a Spanish heritage. Under this agreement, Medis distributes eight specialty medicines in ten countries within the CEE region. The partnership aims to provide new treatment options to patients in CEE, addressing the healthcare needs of this complex region.

Key Company Profiles

The report delves into recent significant developments in the Specialty Drug Distribution Market, highlighting leading vendors and their innovative profiles. These include Aark Pharmaceuticals, Accredo Health Group, Inc., AmerisourceBergen Corporation, BioCare, Inc., Cardinal Health, Inc., Centene Corporation, China National Pharmaceutical Group Corporation, CVS Specialty, Inc. by CVS Health Corporation, Elevance Health, Inc., Eversana, Feron Healthcare Pvt Ltd., FFF Enterprises Inc., Kroger Specialty Pharmacy, Lifeline Pharmaceuticals, LLC, Marken by United Parcel Service, Inc., McKesson Corporation, Medipal Holdings Corporation, Medis Intago, d.o.o., Morris & Dickson Co., LLC, Optum, Inc., PHOENIX Pharmahandel GmbH & Co KG, Shanghai Pharmaceuticals Group Co., Ltd., Shields Health Solutions Holdings, LLC, Sun Pharmaceutical Industries Limited, Suzuken Co., Ltd., Teva Pharmaceutical Industries Ltd., and Walmart Inc.

This research report offers invaluable insights into various crucial aspects of the Specialty Drug Distribution Market:

  1. Market Penetration: This section thoroughly overviews the current market landscape, incorporating detailed data from key industry players.
  2. Market Development: The report examines potential growth prospects in emerging markets and assesses expansion opportunities in mature segments.
  3. Market Diversification: This includes detailed information on recent product launches, untapped geographic regions, recent industry developments, and strategic investments.
  4. Competitive Assessment & Intelligence: An in-depth analysis of the competitive landscape is conducted, covering market share, strategic approaches, product range, certifications, regulatory approvals, patent analysis, technology developments, and advancements in the manufacturing capabilities of leading market players.
  5. Product Development & Innovation: This section offers insights into upcoming technologies, research and development efforts, and notable advancements in product innovation.

Additionally, the report addresses key questions to assist stakeholders in making informed decisions:

  1. What is the current market size and projected growth?
  2. Which products, segments, applications, and regions offer promising investment opportunities?
  3. What are the prevailing technology trends and regulatory frameworks?
  4. What is the market share and positioning of the leading vendors?
  5. What revenue sources and strategic opportunities do vendors in the market consider when deciding to enter or exit?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary4. Market Overview
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing specialty drug development pipeline and trade
5.1.1.2. Emphasis on drug cost, supply, and storage optimization to offer patient-centric care
5.1.2. Restraints
5.1.2.1. Complexity in managing different distribution channels
5.1.3. Opportunities
5.1.3.1. New technology integration and advancements in specialty drug distribution
5.1.3.2. Rising expansion of specialty pharmacies worldwide
5.1.4. Challenges
5.1.4.1. Changing regulatory frameworks associated with specialty drug handling
5.2. Market Segmentation Analysis
5.2.1. Disease Indication: Escalated need of specialty drugs to treat oncology conditions
5.2.2. Distributor Type: Rising presence of full line wholesalers of speciality drugs
5.2.3. Distribution Type: Significant penetration in specialty pharmacies
5.2.4. End-User: Emerging potential for specialty drug distribution in home settings
5.3. Market Trend Analysis
5.3.1. Introduction of new digital ecosystems focusing on improving the distribution of specialty drugs in the Americas
5.3.2. Focus on specialty drug distribution network expansion in the Asia-Pacific region
5.3.3. Government initiatives for rare disease management and well-established pharma companies expand the market growth
5.4. Cumulative Impact of Russia-Ukraine Conflict
5.5. Cumulative Impact of High Inflation
5.6. Porter’s Five Forces Analysis
5.6.1. Threat of New Entrants
5.6.2. Threat of Substitutes
5.6.3. Bargaining Power of Customers
5.6.4. Bargaining Power of Suppliers
5.6.5. Industry Rivalry
5.7. Value Chain & Critical Path Analysis
5.8. Regulatory Framework Analysis
6. Specialty Drug Distribution Market, by Disease Indication
6.1. Introduction
6.2. AIDS
6.3. Hemophilia
6.4. Multiple Sclerosis
6.5. Oncology
6.6. Rheumatoid Arthritis
7. Specialty Drug Distribution Market, by Distributor Type
7.1. Introduction
7.2. Full line Wholesalers
7.3. Specialty Distributors
8. Specialty Drug Distribution Market, by Distribution Type
8.1. Introduction
8.2. Hospitals & Clinic Pharmacies
8.3. Independent Pharmacies
8.4. Large Chain Pharmacies
8.5. Mail-Order Pharmacies
8.6. Online Stores
8.7. Specialty Pharmacies
9. Specialty Drug Distribution Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Healthcare Payers
9.4. Home Settings
9.5. Hospital & Clinics
10. Americas Specialty Drug Distribution Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Specialty Drug Distribution Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Specialty Drug Distribution Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. Market Share Analysis, 2023
13.2. FPNV Positioning Matrix, 2023
13.3. Competitive Scenario Analysis
13.3.1. FFF Enterprises Announces its Partnership with Verrica Pharmaceuticals to be the Exclusive Distributor of YCANTH, the First FDA Approved Treatment for Molluscum Contagiosum
13.3.2. Orsini Specialty Pharmacy Selected to be the Exclusive Specialty Pharmacy Partner for VEOPOZ (pozelimab-bbfg), the First and Only Treatment for CHAPLE Disease
13.3.3. Medis and ESTEVE Signed a Distribution Agreement for 10 CEE Countries
13.3.4. Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
13.3.5. Elevance Health Announces Closing of BioPlus Acquisition
13.3.6. CVS Health to acquire Oak Street Health
13.3.7. Shields Health Solutions and MyMichigan Health Partner to Enhance Specialty Pharmacy Services for Patients and Families
13.3.8. Shields Health Solutions Expands Nationwide Partnerships to Enhance Specialty Pharmacy Services
13.3.9. Prime Therapeutics Closes USD 1.35 Billion Magellan Rx Acquisition, Uniting Pharmacy and Medical Drug Management Expertise
13.3.10. McKesson Canada Launches New Digital Ecosystem to Simplify and Enhance Specialty Patient Outcomes
13.3.11. Manulife and Shoppers Drug Mart Collaborate to Help Manage Serious Medical Conditions
13.3.12. Marken Reaches Agreement to Acquire the Medical Courier Business of Cedra Express, Expands Direct Presence in New Zealand
13.3.13. Cardinal Health Continues to Expand at-Home Solutions Business
13.3.14. Halozyme to Acquire Antares Pharma for Around USD 960 Million
14. Competitive Portfolio
14.1. Key Company Profiles
14.2. Key Product Portfolio
List of Figures
FIGURE 1. SPECIALTY DRUG DISTRIBUTION MARKET RESEARCH PROCESS
FIGURE 2. SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2023 VS 2030
FIGURE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. SPECIALTY DRUG DISTRIBUTION MARKET DYNAMICS
FIGURE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2030 (%)
FIGURE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2023 VS 2030 (%)
FIGURE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2030 (%)
FIGURE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
FIGURE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 16. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 18. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 23. SPECIALTY DRUG DISTRIBUTION MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 24. SPECIALTY DRUG DISTRIBUTION MARKET, FPNV POSITIONING MATRIX, 2023
List of Tables
TABLE 1. SPECIALTY DRUG DISTRIBUTION MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2018-2023 (USD MILLION)
TABLE 4. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, 2024-2030 (USD MILLION)
TABLE 5. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
TABLE 6. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
TABLE 7. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 8. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 9. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY REGION, 2018-2023 (USD MILLION)
TABLE 10. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AIDS, BY REGION, 2024-2030 (USD MILLION)
TABLE 11. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY REGION, 2018-2023 (USD MILLION)
TABLE 12. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEMOPHILIA, BY REGION, 2024-2030 (USD MILLION)
TABLE 13. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 14. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MULTIPLE SCLEROSIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 15. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
TABLE 16. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
TABLE 17. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2018-2023 (USD MILLION)
TABLE 18. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY RHEUMATOID ARTHRITIS, BY REGION, 2024-2030 (USD MILLION)
TABLE 19. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 20. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 21. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 22. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY FULL LINE WHOLESALERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 23. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY REGION, 2018-2023 (USD MILLION)
TABLE 24. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY DISTRIBUTORS, BY REGION, 2024-2030 (USD MILLION)
TABLE 25. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 26. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 27. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CLINIC PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 28. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITALS & CLINIC PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 29. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 30. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY INDEPENDENT PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 31. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 32. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY LARGE CHAIN PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 33. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL-ORDER PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 34. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY MAIL-ORDER PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 35. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY REGION, 2018-2023 (USD MILLION)
TABLE 36. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY ONLINE STORES, BY REGION, 2024-2030 (USD MILLION)
TABLE 37. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2018-2023 (USD MILLION)
TABLE 38. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY SPECIALTY PHARMACIES, BY REGION, 2024-2030 (USD MILLION)
TABLE 39. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 40. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 41. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 42. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 43. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2018-2023 (USD MILLION)
TABLE 44. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HEALTHCARE PAYERS, BY REGION, 2024-2030 (USD MILLION)
TABLE 45. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME SETTINGS, BY REGION, 2018-2023 (USD MILLION)
TABLE 46. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOME SETTINGS, BY REGION, 2024-2030 (USD MILLION)
TABLE 47. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2018-2023 (USD MILLION)
TABLE 48. GLOBAL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY HOSPITAL & CLINICS, BY REGION, 2024-2030 (USD MILLION)
TABLE 49. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 50. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 51. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 52. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 53. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 54. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 55. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 56. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 57. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 58. AMERICAS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 59. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 60. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 61. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 62. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 63. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 64. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 65. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 66. ARGENTINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 67. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 68. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 69. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 70. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 71. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 72. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 73. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 74. BRAZIL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 75. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 76. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 77. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 78. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 79. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 80. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 81. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 82. CANADA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 83. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 84. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 85. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 86. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 87. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 88. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 89. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 90. MEXICO SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 91. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 92. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 93. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 94. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 95. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 96. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 97. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 98. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 99. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
TABLE 100. UNITED STATES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
TABLE 101. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 102. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 103. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 104. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 105. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 106. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 107. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 108. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 109. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 110. ASIA-PACIFIC SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 111. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 112. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 113. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 114. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 115. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 116. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 117. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 118. AUSTRALIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 119. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 120. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 121. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 122. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 123. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 124. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 125. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 126. CHINA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 127. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 128. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 129. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 130. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 131. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 132. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 133. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 134. INDIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 135. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 136. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 137. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 138. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 139. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 140. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 141. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 142. INDONESIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 143. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 144. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 145. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 146. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 147. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 148. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 149. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 150. JAPAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 151. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 152. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 153. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 154. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 155. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 156. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 157. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 158. MALAYSIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 159. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 160. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 161. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 162. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 163. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 164. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 165. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 166. PHILIPPINES SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 167. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 168. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 169. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 170. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 171. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 172. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 173. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 174. SINGAPORE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 175. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 176. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 177. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 178. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 179. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 180. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 181. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 182. SOUTH KOREA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 183. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 184. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 185. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 186. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 187. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 188. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 189. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 190. TAIWAN SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 191. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 192. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 193. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 194. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 195. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 196. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 197. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 198. THAILAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 199. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 200. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 201. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 202. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 203. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 204. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 205. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 206. VIETNAM SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 207. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 208. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 209. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 210. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 211. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 212. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 213. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 214. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 215. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
TABLE 216. EUROPE, MIDDLE EAST & AFRICA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
TABLE 217. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 218. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 219. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 220. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 221. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 222. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 223. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 224. DENMARK SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 225. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 226. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 227. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 228. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 229. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 230. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 231. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 232. EGYPT SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 233. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 234. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 235. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 236. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 237. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 238. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 239. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 240. FINLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 241. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 242. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 243. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 244. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 245. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 246. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 247. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 248. FRANCE SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 249. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 250. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 251. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 252. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 253. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 254. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 255. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 256. GERMANY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 257. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 258. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 259. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 260. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 261. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 262. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 263. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 264. ISRAEL SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 265. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 266. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 267. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 268. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 269. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 270. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 271. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 272. ITALY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 273. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 274. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 275. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 276. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 277. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 278. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 279. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 280. NETHERLANDS SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 281. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 282. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 283. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 284. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 285. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 286. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 287. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 288. NIGERIA SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 289. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 290. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 291. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 292. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 293. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 294. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 295. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 296. NORWAY SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 297. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 298. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 299. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 300. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 301. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 302. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 303. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 304. POLAND SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
TABLE 305. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2018-2023 (USD MILLION)
TABLE 306. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISEASE INDICATION, 2024-2030 (USD MILLION)
TABLE 307. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2018-2023 (USD MILLION)
TABLE 308. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTOR TYPE, 2024-2030 (USD MILLION)
TABLE 309. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2018-2023 (USD MILLION)
TABLE 310. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY DISTRIBUTION TYPE, 2024-2030 (USD MILLION)
TABLE 311. QATAR SPECIALTY DRUG DISTRIBUTION MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
TABLE 312. QATAR SP

Companies Mentioned

  • Aark Pharmaceuticals
  • Accredo Health Group, Inc.
  • AmerisourceBergen Corporation
  • BioCare, Inc.
  • Cardinal Health, Inc.
  • Centene Corporation
  • China National Pharmaceutical Group Corporation
  • CVS Specialty, Inc. by CVS Health Corporation
  • Elevance Health, Inc.
  • Eversana
  • Feron Healthcare Pvt Ltd.
  • FFF Enterprises Inc.
  • Kroger Specialty Pharmacy
  • Lifeline Pharmaceuticals, LLC
  • Marken by United Parcel Service, Inc.
  • McKesson Corporation
  • Medipal Holdings Corporation
  • Medis Intago, d.o.o.
  • Morris & Dickson Co., LLC
  • Optum, Inc.
  • PHOENIX Pharmahandel GmbH & Co KG
  • Shanghai Pharmaceuticals Group Co., Ltd.
  • Shields Health Solutions Holdings, LLC
  • Sun Pharmaceutical Industries Limited
  • Suzuken Co., Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Walmart Inc.

Methodology

Loading
LOADING...

Table Information

Report AttributeDetails
No. of Pages192
PublishedMay 2024
Forecast Period2024 - 2030
Estimated Market Value ( USD ) in 2024 $ 5.47 Billion
Forecasted Market Value ( USD ) by 2030 $ 12.25 Billion
Compound Annual Growth Rate14.4%
Regions CoveredGlobal
No. of Companies Mentioned27

Related Topics

Related Reports

Specialty Drug Distribution Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Image

Specialty Drug Distribution Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • 95 Pages
  • Global
From
Global Specialty Pharmaceuticals Market by Type (CNS, Infectious Diseases, Oncology), Product (Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals), Distribution Channel - Forecast 2024-2030 - Product Image

Global Specialty Pharmaceuticals Market by Type (CNS, Infectious Diseases, Oncology), Product (Oral Pharmaceuticals, Parenteral Pharmaceuticals, Transdermal Pharmaceuticals), Distribution Channel - Forecast 2024-2030

  • Report
  • 187 Pages
  • Global
From
Global Darier Disease Drugs Market by Treatment Type (Medication, Surgery), Drugs (Oral Retinoids, Topical Retinoids), Distribution Channel, End- User - Forecast 2024-2030 - Product Image

Global Darier Disease Drugs Market by Treatment Type (Medication, Surgery), Drugs (Oral Retinoids, Topical Retinoids), Distribution Channel, End- User - Forecast 2024-2030

  • Report
  • 198 Pages
  • Global
From
Pharma E-commerce Market Size, Share & Trends Analysis Report By Product Type (Vaccines, Specialty Care, Topical Medicines), By Therapeutic Areas, By Type, By Channel Type, By Platform, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Pharma E-commerce Market Size, Share & Trends Analysis Report By Product Type (Vaccines, Specialty Care, Topical Medicines), By Therapeutic Areas, By Type, By Channel Type, By Platform, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 100 Pages
  • Global
From
Africa Generic Pharmaceutical Market Size, Share & Trends Analysis Report By Type (Simple Generics, Specialty Generics), By Route Of Administration, By Product, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030 - Product Image

Africa Generic Pharmaceutical Market Size, Share & Trends Analysis Report By Type (Simple Generics, Specialty Generics), By Route Of Administration, By Product, By Application, By Distribution Channel, By Region, And Segment Forecasts, 2023 - 2030

  • Report
  • 102 Pages
  • Africa
From

About the Specialty Drug Distribution Market

The Specialty Drug Distribution market is a segment of the pharmaceutical industry that focuses on the distribution of specialty drugs. These drugs are typically high-cost, complex medications that require special handling and storage. Specialty drugs are often used to treat chronic and rare conditions, such as cancer, multiple sclerosis, and HIV/AIDS. Specialty drug distributors are responsible for ensuring that these drugs are delivered to the appropriate healthcare providers in a timely and safe manner. They also provide support services, such as patient education and reimbursement assistance. The Specialty Drug Distribution market is highly regulated, with stringent requirements for drug storage, handling, and distribution. This ensures that the drugs are delivered safely and securely to the appropriate healthcare providers. Some companies in the Specialty Drug Distribution market include McKesson Corporation, AmerisourceBergen Corporation, Cardinal Health, Inc., and Express Scripts Holding Company. Show Less Read more

Copyright © 2002-2024 Research and Markets. All Rights Reserved.